Cargando…
Anticancer Activity of Natural Products and Related Compounds
Autores principales: | De Filippis, Barbara, Fantacuzzi, Marialuigia, Ammazzalorso, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671672/ https://www.ncbi.nlm.nih.gov/pubmed/38003697 http://dx.doi.org/10.3390/ijms242216507 |
Ejemplares similares
-
Anticancer Inhibitors
por: Ammazzalorso, Alessandra, et al.
Publicado: (2022) -
Development of CDK4/6 Inhibitors: A Five Years Update
por: Ammazzalorso, Alessandra, et al.
Publicado: (2021) -
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection
por: Fantacuzzi, Marialuigia, et al.
Publicado: (2022) -
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
por: Maccallini, Cristina, et al.
Publicado: (2022) -
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro
por: Gallorini, Marialucia, et al.
Publicado: (2019)